Bill
Bill > SB490
MD SB490
MD SB490Maryland Medical Assistance Program - Step Therapy, Fail-First Protocols, and Prior Authorization - Prescription Drugs to Treat Serious Mental Illness
summary
Introduced
02/02/2026
02/02/2026
In Committee
02/02/2026
02/02/2026
Crossed Over
Passed
Dead
Introduced Session
2026 Regular Session
Bill Summary
Prohibiting the Maryland Medical Assistance Program from applying a prior authorization requirement in certain circumstances to and from applying a step therapy or fail-first protocol for a prescription drug used to treat an adult enrollee's diagnosis of bipolar disorder, schizophrenia, major depression, post-traumatic stress disorder, or a medication-induced movement disorder associated with the treatment of serious mental illness.
AI Summary
This bill, effective July 1, 2026, prohibits the Maryland Medical Assistance Program from requiring prior authorization or applying "step therapy or fail-first protocols" for prescription drugs used to treat adults diagnosed with serious mental illnesses including bipolar disorder, schizophrenia, major depression, post-traumatic stress disorder, or medication-induced movement disorders associated with these conditions. Step therapy or fail-first protocols, as defined in other Maryland law, require patients to try certain less expensive medications before a more expensive one is approved, and this bill aims to remove that hurdle for these specific mental health treatments. This prohibition will remain in effect for three years, until June 30, 2029.
Committee Categories
Budget and Finance
Sponsors (1)
Last Action
Senate Finance Hearing (13:00:00 2/17/2026 ) (on 02/17/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/SB0490?ys=2026RS |
| BillText | https://mgaleg.maryland.gov/2026RS/bills/sb/sb0490f.pdf |
Loading...